Newest by Date
Newest by Title
Oldest by Date
Oldest by Title
Is life sciences ready for post-pandemic transformation?
Preparing for the next era of clinical development and therapy commercialization, companies must choose: move forward with innovations spurred by the pandemic or retrench into default practices.
Q&A: Advantages of external control arm studies
Applying real-world data to external control arm studies for regulatory submissions can help life sciences companies bring treatments to patients.